Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma.

Authors:
Xu L; Chen S; Li Q; Chen X; Xu Y and 5 more

Journal:
Cancer Cell Int

Publication Year: 2024

DOI:
10.1186/s12935-023-03208-x

PMCID:
PMC10788009

PMID:
38218909

Journal Information

Full Title: Cancer Cell Int

Abbreviation: Cancer Cell Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe First Affiliated Hospital of Zhengzhou University’s Ethics Committee approved this study in accordance with the Declaration of Helsinki. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the Henan Medical Science and Technology Joint Building Program (no. LHGJ20190255, LHGJ20190262, LHGJ20230239)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025